Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Aug 25, 2025
FLORHAM PARK, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following investor conferences in September:
Read more at globenewswire.com
